Articles citing this paper

Patterns of real-world opioid prescribing in Australian general practice (2013–18)

Doreen Busingye

^A ^C , Benjamin Daniels ^A ^B , Jonathan Brett ^B , Allan Pollack ^A , Josephine Belcher ^A , Kendal Chidwick

^A and Suzanne Blogg ^A

+ Author Affiliations

- Author Affiliations

^A NPS MedicineWise, Level 7/418A Elizabeth Street, Surry Hills, NSW 2010, Australia.

^B Medicines Policy Research Unit, Centre for Big Data Research in Health, Level 2, AGSM Building (G27), UNSW, Sydney, NSW 2052, Australia.

^C Corresponding author. Email: dbusingye@nps.org.au

Australian Journal of Primary Health 27(5) 416-424 https://doi.org/10.1071/PY20270
Submitted: 12 November 2020 Accepted: 25 May 2021 Published: 15 September 2021

9 articles found in Crossref database.

Cohort profile: POPPY II – a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia

Gisev Natasa, Pearson Sallie-Anne, Dobbins Timothy, Buizen Luke, Murphy Thomas, Wilson Andrew, Blyth Fiona, Dunlop Adrian, Larney Sarah, Currow David C, Mattick Richard P, Degenhardt Louisa

BMJ Open. 2023 13(5). p.e068310

[Crossref]

The impact of tightened prescribing restrictions for PBS‐subsidised opioid medicines and the introduction of half‐pack sizes, Australia, 2020–21: an interrupted time series analysis

Koch Forrest C, Olivier Jake, Brett Jonathan, Buckley Nicholas A, Gisev Natasa, Pearson Sallie, Daniels Benjamin

Medical Journal of Australia. 2024 220(6). p.315

[Crossref]

Interventions for reducing the prescribing of pharmaceutical opioids in Australia: are they effectively reducing opioid harm?

Nielsen Suzanne, Xia Ting

Medical Journal of Australia. 2024 220(6). p.311

[Crossref]

Oxycodone initiation in Australia (2014–2018): Sociodemographic factors and preceding health service use

Gillies Malcolm B., Camacho Ximena, Bharat Chrianna, Buizen Luke, Blyth Fiona, Currow David, Wilson Andrew, Degenhardt Louisa, Gisev Natasa, Pearson Sallie‐Anne

British Journal of Clinical Pharmacology. 2024

[Crossref]

Twenty-year trends in pharmaceutical fentanyl and illicit fentanyl deaths, Australia 2001–2021

Roxburgh Amanda, Nielsen Suzanne

International Journal of Drug Policy. 2022 109 p.103854

[Crossref]

Opioid prescribing patterns among medical practitioners in New South Wales, Australia

Schaffer Andrea L., Gisev Natasa, Blyth Fiona M., Buckley Nicholas A., Currow David, Dobbins Timothy A., Wilson Andrew, Degenhardt Louisa, Pearson Sallie‐Anne

Drug and Alcohol Review. 2023 42(6). p.1472

[Crossref]

Effect of discharge opioid on persistent postoperative opioid use: a retrospective cohort study comparing tapentadol with oxycodone

Lam T., Xia T., Biggs N., Treloar M., Cheng O., Kabu K., Stevens J. A., Evans J. D., da Gama M. E., Lubman D. I., Nielsen S.

Anaesthesia. 2023 78(4). p.420

[Crossref]

Using primary care data to understand opioid prescribing, policy impacts and clinical outcomes: A protocol for the OPPICO study

Cangadis-Douglass Helena, Jung Monica, Xia Ting, Buchbinder Rachelle, Lalic Samanta, Russell Grant, Andrew Nadine, Pearce Christopher, Bell J Simon, Ilomäki Jenni, Nielsen Suzanne

Research in Social and Administrative Pharmacy. 2022 18(12). p.4129

[Crossref]

Quality use of publicly subsidised tapentadol in Australia: a population‐based analysis

Camacho Ximena, Schaffer Andrea L., Brett Jonathan, Pratt Nicole, Buckley Nicholas A., Henry David, Pearson Sallie‐Anne

Internal Medicine Journal. 2024

[Crossref]